RecruitingNCT05926622

Clinical and Radiological Outcomes of Medacta Shoulder System FR

Clinical and Radiological Outcomes of Medacta Shoulder System


Sponsor

Medacta International SA

Enrollment

200 participants

Start Date

Mar 15, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This is a post-marketing surveillance on Medacta Shoulder System


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tracks the long-term outcomes of patients who receive the Medacta shoulder replacement system, looking at how well it functions and what the X-rays show over time. **You may be eligible if...** - You are over 18 years old - You need a shoulder replacement for conditions such as osteoarthritis, a torn rotator cuff, a fracture, rheumatoid arthritis, bone death (avascular necrosis), or a revision of a prior shoulder replacement **You may NOT be eligible if...** - You have a current malignant (cancerous) disease - You have a confirmed or suspected joint infection - You have functional problems in other parts of the body that would affect your shoulder recovery - You have a known allergy or incompatibility to the implant materials Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Clinique Générale Annecy

Annecy, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05926622


Related Trials